{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:45:23Z","timestamp":1776660323376,"version":"3.51.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the effectiveness and safety of an endocrinologist-led glucose management (ELGM) model integrating real-time continuous glucose monitoring (RT-CGM) and continuous insulin infusion therapy, compared with conventional glucose management in critically ill patients admitted to the emergency intensive care unit (EICU).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center, retrospective before-after study, adult EICU patients with stays \u226524 hours were included. Patients admitted in 2023 received conventional glucose management (control), whereas those admitted in 2024 were managed using the ELGM model. Endocrinologists served as primary decision-makers, supported by RT-CGM, point-of-care testing, and continuous insulin infusion. Primary outcomes included mean glucose, glycemic variability, proportion of target-range glucose (3.9 - 10.0 mmol\/L), and hypo-\/hyperglycemia incidence. Secondary outcomes included nosocomial infection, hyperosmolar hyperglycemic state (HHS), length of stay, ventilation duration, and hospitalization costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1138 patients were analyzed (ELGM 625; Control 513). Compared with conventional management, the ELGM model was associated with lower mean glucose (9.9 vs. 11.1 mmol\/L; P&amp;lt; 0.001) and reduced variability (SD 4.2 vs. 4.9 mmol\/L; P&amp;lt; 0.001). Target-range readings were higher (61.11% vs. 51.66%; P&amp;lt; 0.001), and severe hyperglycemia was less frequent (7.45% vs. 13.28%; P&amp;lt; 0.001). Severe hypoglycemia did not differ. Nosocomial infection (15.02% vs. 27.68%) and HHS (1.28% vs. 5.65%) were lower (both P&amp;lt; 0.001). Length of stay and costs were similar, while ventilation duration was slightly longer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>An endocrinologist-led glucose management strategy incorporating RT-CGM was associated with improved glycemic metrics and lower rates of severe hyperglycemia and infection, supporting its feasibility in critically ill patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1790977","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:14:12Z","timestamp":1776658452000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Endocrinologist-led glucose management in the emergency ICU: a retrospective before-after study"],"prefix":"10.3389","volume":"17","author":[{"given":"Long","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Endocrinology, The Affiliated LihuiLi Hospital of Ningbo University","place":["Ningbo, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhang-Sheng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Transfusion Medicine Center, Apheresis and Transfusion Therapy Center, The Affiliated LihuiLi Hospital of Ningbo University","place":["Ningbo, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Xia","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Affiliated LihuiLi Hospital of Ningbo University","place":["Ningbo, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Li","family":"Ma","sequence":"additional","affiliation":[{"name":"Transfusion Medicine Center, Apheresis and Transfusion Therapy Center, The Affiliated LihuiLi Hospital of Ningbo University","place":["Ningbo, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Fang","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Affiliated LihuiLi Hospital of Ningbo University","place":["Ningbo, Zhejiang, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3287-7","article-title":"Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality","volume":"40","author":"Plummer","year":"2014","journal-title":"Intensive Care Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020995","article-title":"Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes","volume":"88","author":"Cakir","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.051029","article-title":"Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease","volume":"61","author":"Baker","year":"2006","journal-title":"Thorax"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-01874-7","article-title":"Glycemic variability assessed by continuous glucose monitoring in hospitalized patients with community-acquired pneumonia","volume":"22","author":"Olsen","year":"2022","journal-title":"BMC Pulm Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.08.002","article-title":"American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update","volume":"28","author":"Blonde","year":"2022","journal-title":"Endocr Pract"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S016","article-title":"Diabetes Care in the Hospital: Standards of Care in Diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000006174","article-title":"Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024","volume":"52","author":"Honarmand","year":"2024","journal-title":"Crit Care Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00468-4","article-title":"Shared decision making in endocrinology: present and future directions","volume":"4","author":"Rodriguez-Gutierrez","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13143","article-title":"Shared decision-making in the care of individuals with diabetes","volume":"33","author":"Serrano","year":"2016","journal-title":"Diabet Med"},{"key":"B10","article-title":"In-hospital management of type 2 diabetes in Denmark is inconsistent with international guidelines","volume":"70","author":"Olsen","year":"2022","journal-title":"Dan Med J"},{"key":"B11","article-title":"Management of diabetes and hyperglycaemia in non-intensive care units","volume":"185","author":"Olsen","year":"2023","journal-title":"Ugeskr Laeger"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4158\/EP.15.1.24","article-title":"Continuous subcutaneous insulin infusion (insulin pump) therapy can be safely used in the hospital in select patients","volume":"15","author":"Bailon","year":"2009","journal-title":"Endocr Pract"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30381-8","article-title":"Management of diabetes and hyperglycaemia in the hospital","volume":"9","author":"Pasquel","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06206-4","article-title":"Technology in the management of diabetes in hospitalised adults","volume":"67","author":"Thabit","year":"2024","journal-title":"Diabetologia"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjoq-2017-000059","article-title":"Effectiveness of a multi-component quality improvement intervention on rates of hyperglycaemia","volume":"6","author":"Franco","year":"2017","journal-title":"BMJ Open Qual"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4158\/EP-2019-0264","article-title":"Implementation of an Electronic Dashboard With a Remote Management System to Improve Glycemic Management Among Hospitalized Adults","volume":"26","author":"Sheen","year":"2020","journal-title":"Endocr Pract"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13500","article-title":"Electronic dashboard-based remote glycemic management program reduces length of stay and readmission rate among hospitalized adults","volume":"12","author":"Sheen","year":"2021","journal-title":"J Diabetes Investig"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac277","article-title":"A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline for the Management of Hyperglycemia in Adults Hospitalized for Noncritical Illness or Undergoing Elective Surgical Procedures","volume":"107","author":"Seisa","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/CNQ.0000000000000288","article-title":"Individualizing Glycemic Control in the Critically Ill","volume":"43","author":"Murphy","year":"2020","journal-title":"Crit Care Nurs Q"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v12.i10.1719","article-title":"Glycemic targets in critically ill adults: A mini-review","volume":"12","author":"See","year":"2021","journal-title":"World J Diabetes"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304855","article-title":"Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU","volume":"389","author":"Gunst","year":"2023","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1177\/19322968231191104","article-title":"A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials","volume":"17","author":"Spanakis","year":"2023","journal-title":"J Diabetes Sci Technol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/1932296821994586","article-title":"Feasibility of Real-Time Continuous Glucose Monitoring Telemetry System in an Inpatient Diabetes Unit: A Pilot Study","volume":"16","author":"Dillmann","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01242-3","article-title":"Comparison of in-patient glucose team based management with conventional blood glucose management- a retrospective study from China","volume":"16","author":"Lin","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101067","article-title":"Real-time continuous glucose monitoring-guided glucose management in inpatients with diabetes receiving short-term continuous subcutaneous insulin infusion: a randomized clinical trial","volume":"48","author":"Wang","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2025.02.006","article-title":"Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients: A Randomized Controlled Trial","volume":"168","author":"Franck","year":"2025","journal-title":"Chest"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012138","article-title":"Continuous glucose monitoring system can improve the quality of glucose control and glucose variability compared with point-of-care measurement in critically ill patients: A randomized controlled trial","volume":"97","author":"Lu","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1352","article-title":"Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial","volume":"33","author":"Holzinger","year":"2010","journal-title":"Diabetes Care"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0453-9","article-title":"Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial","volume":"18","author":"Boom","year":"2014","journal-title":"Crit Care"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2015.0151","article-title":"Randomized Evaluation of Glycemic Control in the Medical Intensive Care Unit Using Real-Time Continuous Glucose Monitoring (REGIMEN Trial)","volume":"17","author":"De Block","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1067\/mtc.2003.181","article-title":"Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting","volume":"125","author":"Furnary","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2.553","article-title":"Management of diabetes and hyperglycemia in hospitals","volume":"27","author":"Clement","year":"2004","journal-title":"Diabetes Care"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4158\/EP.12.S3.43","article-title":"Financial implications of glycemic control: results of an inpatient diabetes management program","volume":"12","author":"Newton","year":"2006","journal-title":"Endocr Pract"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S468929","article-title":"Towards a Region-Wide Glycaemic Management System: Strategies and Applications for Glycaemic Management of Patients with Diabetes During Hospitalisation","volume":"17","author":"He","year":"2024","journal-title":"J Multidiscip Healthc"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1790977\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T04:14:13Z","timestamp":1776658453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1790977\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":34,"alternative-id":["10.3389\/fendo.2026.1790977"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1790977","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"article-number":"1790977"}}